BRIEF-ArQule shares tumble following news experimental cancer drug fails

NEW YORK Fri Jan 11, 2013 8:04am EST

NEW YORK Jan 11 (Reuters) - ArQule Inc : * Shares down 20 percent in premarket trade on news experimental cancer drug

fails mid-stage study

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.